Literature DB >> 17883696

Fibrinogen angers with a new deletion (gamma GVYYQ 346-350) causes hypofibrinogenemia with hepatic storage.

N Dib1, F Quelin, C Ternisien, M Hanss, S Michalak, P De Mazancourt, M C Rousselet, P Calès.   

Abstract

INTRODUCTION: This study reports a family with chronically abnormal blood liver function tests (LFT) and congenital hypofibrinogenemia. The proposita had cirrhosis initially related to alcohol abuse and chronic viral hepatitis C (HCV), but abnormal LFT persisted even when alcohol intake was stopped and despite HCV treatment was efficient based on serum RNA negative testing.
RESULTS: Needle biopsy specimens of the proposita and her brother showed eosinophilic intra-cytoplasmic inclusions that reacted strongly with fibrinogen antisera on direct immunofluorescence. Electron microscopic examination showed that the rough endoplasmic reticulum was filled with inclusions that consisted of densely packed, curved tubular structures arranged in a fingerprint-like pattern. Coagulation studies revealed low functional and antigenic fibrinogen concentrations suggestive of hypofibrinogenemia. Amplification and DNA sequencing showed a heterozygous deletion of the a7690 to g7704 nucleotides of the gamma chain gene in the 3'end of exon 8 (g 7690_7704del14; Genbank access M10014); this deletion encompassed the splicing site at position 7703 and predicts in a new putative consensus splicing sequence (AATGgtatgtt). RNA was extracted from a liver specimen from the proposita's brother. The cDNA obtained by reverse transcription polymerase chain reaction confirmed the usage of a newly generated donor site at position 7688 of the genomic sequence resulting in an in-frame heterozygous 5 amino acid deletion (GVYYQ 346-350; p.G372_Q376del) and that this mutation is responsible for a new splicing site at position 7688 of the genomic sequence.
CONCLUSION: we suggest that the molecular defect in fibrinogen Angers results in an impaired assembly and causes defective secretion and hepatic storage of fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883696     DOI: 10.1111/j.1538-7836.2007.02713.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

1.  The fibrous form of intracellular inclusion bodies in recombinant variant fibrinogen-producing cells is specific to the hepatic fibrinogen storage disease-inducible variant fibrinogen.

Authors:  Shinpei Arai; Naoko Ogiwara; Saki Mukai; Yuka Takezawa; Mitsutoshi Sugano; Takayuki Honda; Nobuo Okumura
Journal:  Int J Hematol       Date:  2017-02-04       Impact factor: 2.490

2.  Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.

Authors:  Masahiro Yoda; Takahiro Kaido; Tomu Kamijo; Chiaki Taira; Yumiko Higuchi; Shinpei Arai; Nobuo Okumura
Journal:  Int J Hematol       Date:  2021-06-12       Impact factor: 2.490

Review 3.  Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.

Authors:  Marguerite Neerman-Arbez; Alessandro Casini
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

4.  Hepatic fibrinogen storage disease due to the fibrinogen γ375 Arg → Trp mutation "fibrinogen Aguadilla" is present in Arabs.

Authors:  Abdulrahman Al-Hussaini; Abdulhadi Altalhi; Imad El Hag; Hussa AlHussaini; Paola Francalanci; Isabella Giovannoni; Francesco Callea
Journal:  Saudi J Gastroenterol       Date:  2014 Jul-Aug       Impact factor: 2.485

5.  Fibrinogen storage disease in a Chinese boy with de novo fibrinogen Aguadilla mutation: Incomplete response to carbamazepine and ursodeoxycholic acid.

Authors:  Mei-Hong Zhang; A S Knisely; Neng-Li Wang; Jing-Yu Gong; Jian-She Wang
Journal:  BMC Gastroenterol       Date:  2016-08-12       Impact factor: 3.067

6.  Fibrinogen Gamma Chain Mutations Provoke Fibrinogen and Apolipoprotein B Plasma Deficiency and Liver Storage.

Authors:  Francesco Callea; Isabella Giovannoni; Sinan Sari; Esendagli Guldal; Buket Dalgic; Gulen Akyol; Tsuyoshi Sogo; Abdulrahman Al-Hussaini; Giuseppe Maggiore; Andrea Bartuli; Renata Boldrini; Paola Francalanci; Emanuele Bellacchio
Journal:  Int J Mol Sci       Date:  2017-12-15       Impact factor: 5.923

7.  Hepatic fibrinogen storage disease and hypofibrinogenemia caused by fibrinogen Aguadilla mutation: a case report.

Authors:  Leilei Gu; Bin Wang; Lu Liu; Qiaorong Gan; Xiaolong Liu; Lihong Chen; Li Chen
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

Review 8.  Hereditary Hypofibrinogenemia with Hepatic Storage.

Authors:  Rosanna Asselta; Elvezia Maria Paraboschi; Stefano Duga
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

9.  Structural Characteristics in the γ Chain Variants Associated with Fibrinogen Storage Disease Suggest the Underlying Pathogenic Mechanism.

Authors:  Guven Burcu; Emanuele Bellacchio; Elif Sag; Alper Han Cebi; Ismail Saygin; Aysenur Bahadir; Guldal Yilmaz; Marialuisa Corbeddu; Murat Cakir; Francesco Callea
Journal:  Int J Mol Sci       Date:  2020-07-20       Impact factor: 5.923

Review 10.  The Discovery of Endoplasmic Reticulum Storage Disease. The Connection between an H&E Slide and the Brain.

Authors:  Francesco Callea; Valeer Desmet
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.